David R Guyer - Net Worth and Insider Trading
David R Guyer Net Worth
The estimated net worth of David R Guyer is at least $3 Million dollars as of 2025-07-24. David R Guyer is the Executive Chairman of IVERIC bio Inc and owns about 70,113 shares of IVERIC bio Inc (ISEE) stock worth over $3 Million. David R Guyer is also the Director of EyePoint Pharmaceuticals Inc and owns about 1,850 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $19,416. Details can be seen in David R Guyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David R Guyer has not made any transactions after 2024-07-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of David R Guyer
David R Guyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David R Guyer owns 3 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , IVERIC bio Inc (ISEE) , and Applied Genetic Technologies Corp (AGTC) .
Click here to see the complete history of David R Guyer’s form 4 insider trades.
Insider Ownership Summary of David R Guyer
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
EYPT | EyePoint Pharmaceuticals Inc | 2024-07-12 | director |
ISEE | IVERIC bio Inc | 2020-12-14 | director & Chief Executive Officer |
AGTC | Applied Genetic Technologies Corp | 2014-06-27 | director |
David R Guyer Latest Holdings Summary
David R Guyer currently owns a total of 2 stocks. Among these stocks, David R Guyer owns 70,113 shares of IVERIC bio Inc (ISEE) as of December 14, 2020, with a value of $3 Million and a weighting of 99.31%. David R Guyer also owns 1,850 shares of EyePoint Pharmaceuticals Inc (EYPT) as of July 12, 2024, with a value of $19,416 and a weighting of 0.69%.
Latest Holdings of David R Guyer
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ISEE | IVERIC bio Inc | 2020-12-14 | 70,113 | 39.95 | 2,801,014 |
EYPT | EyePoint Pharmaceuticals Inc | 2024-07-12 | 1,850 | 10.50 | 19,416 |
Holding Weightings of David R Guyer
David R Guyer Form 4 Trading Tracker
According to the SEC Form 4 filings, David R Guyer has made a total of 2 transactions in IVERIC bio Inc (ISEE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in IVERIC bio Inc is the sale of 9,270 shares on December 14, 2020, which brought David R Guyer around $66,373.
According to the SEC Form 4 filings, David R Guyer has made a total of 3 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the sale of 11,625 shares on July 12, 2024, which brought David R Guyer around $116,948.
Insider Trading History of David R Guyer
- 1
David R Guyer Trading Performance
David R Guyer Ownership Network
Ownership Network List of David R Guyer
Ownership Network Relation of David R Guyer

David R Guyer Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
David R Guyer is the director of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Medical Officer Dario A. Paggiarino .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, David R Guyer made 3 insider transaction in EyePoint Pharmaceuticals Inc (EYPT) with a net sale of 34,875. Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 38,126 shares made by David Scott Jones , a net purchase of 32,500 shares made by Karen L. Zaderej , and a net purchase of 1,431,765 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 122,926 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 1,475,005 shares were bought by its insiders, resulting in a net purchase of 1,352,079 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
David R Guyer Mailing Address
Above is the net worth, insider trading, and ownership report for David R Guyer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David R Guyer's mailing address is: New York Ny 10119.